AB

American Bio Medica CorpOOTC ABMC Stock Report

Last reporting period 31 Mar, 2023

Updated 15 Nov, 2024

Last price

Market cap $B

0

Micro

Exchange

OOTC - OTC

ABMC Stock Analysis

AB

Uncovered

American Bio Medica Corp is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-30/100

Low score

Market cap $B

0

Dividend yield

Shares outstanding

48.099 B

American Bio Medica Corporation manufactures and sells lateral flow immunoassay tests, primarily for the immediate detection of drugs in urine and oral fluid. The Company manufactures its products in the United States while. One of its drug testing lines is private labeled for another diagnostic company. It also provides strip manufacturing, product assembly and packaging services to an unaffiliated third party related to a diagnostic test that they sell outside the United States and, the Company manufacture a diagnostic product, which is sells under a private label by an unaffiliated third party. It sells, through distribution, a number of other products related to the immediate detection of drugs in urine and oral fluid, as well as offers other point of care diagnostic products via distribution. Its products for the detection of drugs in urine include Rapid Drug Screen, RDS InCup, Rapid TOX and Rapid TOX Cup II. Its product for the detection of drugs in oral fluid includes OralStat.

View Section: Eyestock Rating